We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
LataMed AI Partners with Venezuelan Pharmacies for AI Fulfillment
about 4 hours ago
Innovative Designs Reports Record-Breaking Q2 Revenue Growth
about 5 hours ago
GeoVax Prioritizes GEO-MVA and Gedeptin, Discontinues COVID Vaccine
about 6 hours ago
Beat Summer Fatigue with ORGANA's Oxygen-Support Wellness
about 8 hours ago
Yocale.ai Begins Trading on CSE Under Symbol YAI
about 15 hours ago
HR News
HRO Today's 2026 Talent Acquisition Summit Set for Atlanta
6 days ago
Steyr Motors Appoints Bjorn Krausmann as CFO to Drive Growth
7 days ago
HR Research Institute Forms 2026 Employee Productivity and Engagement Advisory Board
7 days ago
HR.com Honors 2026 HR Tech Innovation Award Winners
12 days ago
CHRO of the Year Awards 2026 Winners Announced at HRO Today Forum
12 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 4 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 4 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 days
Silvercorp Metals Declares Semi-Annual Dividend, Rewards Shareholders
about 4 hours ago
LataMed AI Partners with Venezuelan Pharmacies for AI Fulfillment
about 4 hours ago
Crypto News
Iran Launches Crypto-Powered Maritime Insurance for Hormuz Shipping
4 days ago
Tokenized Real-World Assets Near $30B but Largely Untapped in DeFi
5 days ago
Trump Admin Curbs State Crypto Oversight, Sparks Debate
7 days ago
Saudi Arabia Pushes Tokenization to Transform Economy
7 days ago
ECGI Holdings Launches Rezy.Fi Investor Onboarding for Tokenized Mortgages
7 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 4 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 4 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 4 days
GeoVax Prioritizes GEO-MVA and Gedeptin, Discontinues COVID Vaccine
about 6 hours ago
NeuroOne Restates Q2 Results, Reaffirms FY2026 Revenue Guidance
4 days ago
Technology News
Silvercorp Metals Declares Semi-Annual Dividend, Rewards Shareholders
about 4 hours ago
LataMed AI Partners with Venezuelan Pharmacies for AI Fulfillment
about 4 hours ago
GeoVax Prioritizes GEO-MVA and Gedeptin, Discontinues COVID Vaccine
about 6 hours ago
Yocale.ai Begins Trading on CSE Under Symbol YAI
about 15 hours ago
HeartBeam's Portable ECG System Aims to Revolutionize Cardiac Care
4 days ago
Events & Conferences
ABANCA USA Leads Real Estate Forum 2026 in Miami, Shaping Future Trends
4 days ago
Silvercorp Metals Sets Revised Date for Fiscal 2026 Results
4 days ago
Verizon Drops 2,500+ Free FIFA World Cup 2026 Tickets on June 1
5 days ago
Global Fashion Group AGM Approves All Resolutions, Including Share Buyback Authorization
6 days ago
Western Star Resources to Present at Commodities Global Expo 2026
6 days ago